Expand CRDL Menu
CRDL MENU

CRDL Stock Summary and Trading Ideas (Cardiol Therapeutics - Class A Common Shares | NASDAQ:CRDL)

Charts for Today's Stock Price and Implied Volatility in Cardiol Therapeutics - Class A Common Shares

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for CRDL by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Cardiol Therapeutics - Class A Common Shares (CRDL) Frequently Asked Questions

What does Cardiol Therapeutics - Class A Common Shares do?

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

What symbol and exchange does Cardiol Therapeutics - Class A Common Shares shares trade?

Cardiol Therapeutics - Class A Common Shares trades on the NASDAQ stock market under the symbol CRDL.

What is Cardiol Therapeutics - Class A Common Shares stock price doing today?

As of March 27, 2026, CRDL stock price climbed to $1.25 with 3,367,157 million shares trading.

What is Cardiol Therapeutics - Class A Common Shares's Beta?

CRDL has a beta of 1.69, meaning it tends to be more sensitive to market movements. CRDL has a correlation of 0.14 to the broad based SPY ETF.

How much is Cardiol Therapeutics - Class A Common Shares worth?

CRDL has a market cap of $139.28 million. This is considered a Micro Cap stock.

What is the highest and lowest price Cardiol Therapeutics - Class A Common Shares traded in the last 3 year period?

In the last 3 years, CRDL traded as high as $3.12 and as low as $.45.

Is Cardiol Therapeutics - Class A Common Shares (CRDL) a good investment?

CRDL has outperformed the market in the last year with a price return of +25.5% while the SPY ETF gained +12.8%. CRDL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +25.9% and +19.0%, respectively, while the SPY returned -7.9% and -4.5%, respectively.

What are the support and resistance levels for Cardiol Therapeutics - Class A Common Shares (CRDL)?

CRDL support price is $1.06 and resistance is $1.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRDL shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes